SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)
Germany · Delayed Price · Currency is EUR 14.36
-0.04 (-0.28%)
At close: Jan 30, 2026
FRA:1SXP Market Cap
FRA:1SXP has a market cap or net worth of €2.16 billion as of January 30, 2026. Its market cap has decreased by -43.24% in one year.
Market Cap
2.16B
Enterprise Value
2.44B
Revenue
986.21M
Ranking
n/a
PE Ratio
14.77
Stock Price
€14.36
Market Cap Chart
Since September 28, 2023, FRA:1SXP's market cap has decreased from 4.71B to 2.16B, a decrease of -54.12%. That is a compound annual growth rate of -28.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.16B | -4.90% |
| Dec 30, 2025 | 2.27B | -39.98% |
| Dec 30, 2024 | 3.79B | -25.12% |
| Dec 29, 2023 | 5.06B | 7.35% |
| Sep 28, 2023 | 4.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.59B |
| Siemens Healthineers AG | 47.05B |
| Bayer Aktiengesellschaft | 43.78B |
| Fresenius SE & Co. KGaA | 26.59B |
| Fielmann Group AG | 3.48B |
| Carl Zeiss Meditec AG | 2.45B |
| SCHOTT Pharma AG & Co. KGaA | 2.16B |
| Dermapharm Holding SE | 1.88B |